Vertex Pharmaceuticals Inc. (VRTX) posted a loss of 12 cents per share (including stock-based compensation expense) in the first quarter of 2013,... ...

Novartis (NVS) recently announced that the US Food and Drug Administration (FDA) has approved Simbrinza Suspension for the reduction of elevated... ...

Omeros Corporation (OMER) recently announced that the company has filed an Application for Orphan Drug Designation with the US Food and Drug... ...

Achillion Pharmaceuticals, Inc. (ACHN) recently commenced international phase II studies on sovaprevir and ACH-3102 for the treatment of genotype 1... ...

Actelion Ltd. (ALIOF) reported first quarter 2013 earnings of $1.35 per American Depository Receipt (ADR), up 56.1% from the prior-year earnings of... ...

1. india
2. switzerland
3. biocon
4. biogen idec rank
5. germany
6. basel
7. regeneron pharmaceuticals rank
8. creve coeur
9. monsanto company rank
10. cambridge
11. gilead sciences rank
12. massachusetts
13. denmark click
14. california

Top Coverage News